Brian Scheckner

Statistics

Publications

Citations

255

H-Index

Active since

2010

Affiliations

Takeda (United States)(Current)

Center for Psychiatry and Behavioral Medicine

University Hospitals Cleveland Medical Center

Center for Independent Living

Claghorn Lesem Research Clinic

Brian Scheckner is an author at Takeda (United States) specializing in adhd treatment, adhd pharmacotherapy, and attention-deficit/hyperactivity disorder.

Publications per year

2010–2013

Publications

Attention deficit hyperactivity disorder subtypes and symptom response in adults treated with lisdexamfetamine dimesylate.

Bryan Dirks, T. Babcock, Ben Adeyi et al. · PubMed · 2012 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

The Effects of Lisdexamfetamine Dimesylate on Emotional Lability in Children 6 to 12 Years of Age With ADHD in a Double-Blind Placebo-Controlled Trial

Ann Childress, Valerie Arnold, Ben Adeyi et al. · Journal of Attention Disorders · 2012 · 33 citations

Medicine, Pharmacology, Pharmacotherapy +17

Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

Gregory W. Mattingly, Richard H. Weisler, Joel Young et al. · BMC Psychiatry · 2013 · 31 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Long-term treatment outcomes with lisdexamfetamine dimesylate for adults with attention-deficit/hyperactivity disorder stratified by baseline severity

Lawrence Ginsberg, Alain Katic, Ben Adeyi et al. · Current Medical Research and Opinion · 2011 · 26 citations

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis

T. Babcock, Teodor Burtea, Bryan Dirks et al. · Child and Adolescent Psychiatry and Mental Health · 2011 · 26 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 12